Results for Tangeretin

Enhanced anti-inflammatory activities by the combination of luteolin and tangeretin.

Article Published Date : Apr 30, 2016
Study Type : In Vitro Study
Additional Links
Substances : Luteolin : CK(235) : AC(153), Tangeretin : CK(38) : AC(24)
Diseases : Inflammation : CK(6531) : AC(1986), Lipopolysaccharide-Induced Toxicity : CK(1105) : AC(650)
Pharmacological Actions : Anti-Inflammatory Agents : CK(12461) : AC(4729), Cyclooxygenase 2 Inhibitors : CK(1114) : AC(645), Interleukin-1 beta downregulation : CK(1743) : AC(868), Interleukin-6 Downregulation : CK(3054) : AC(1144), NF-kappaB Inhibitor : CK(2446) : AC(1436)
Additional Keywords : Anti-Inflammatory Agents, Inflammation : CK(2) : AC(2), Lipopolysaccharide-Induced Toxicity, LUTEOLIN, Natural Substance Synergy : CK(844) : AC(392), Tangeretin

Nobiletin and tangeretin may be beneficial in the treatment and prevention of Alzheimer`s and Parkinson's disease.

Article Published Date : Mar 26, 2017
Study Type : In Vitro Study
Additional Links
Substances : Nobiletin : CK(87) : AC(53), Tangeretin : CK(38) : AC(24)
Diseases : Alzheimer's Disease : CK(2442) : AC(871), Parkinson's Disease : CK(1155) : AC(411)
Pharmacological Actions : Neuroprotective Agents : CK(6374) : AC(2801)
Additional Keywords : Alzheimer's disease, Neuroprotective Agents, Nobiletin, Parkinson's disease, Tangeretin

Tangeretin exerted potent neuroprotective effects against pilocarpine-induced seizures.

Article Published Date : Aug 31, 2017
Study Type : Animal Study
Additional Links
Substances : Tangeretin : CK(38) : AC(24)
Diseases : Seizures: Drug-Induced : CK(41) : AC(13)
Pharmacological Actions : Anticonvulsants : CK(534) : AC(146), Neuroprotective Agents : CK(6374) : AC(2801)
Additional Keywords : Anticonvulsants, Neuroprotective Agents, Seizures: Drug-Induced, Tangeretin

Tangeretin inhibits IL-12 expression and NF-κB activation in dendritic cells and attenuates colitis in mice.

Article Published Date : Mar 31, 2017
Study Type : Animal Study
Additional Links
Substances : Tangeretin : CK(38) : AC(24)
Diseases : Colitis : CK(565) : AC(262)
Pharmacological Actions : Anti-Inflammatory Agents : CK(12461) : AC(4729), Interleukin-12 downregulation : CK(9) : AC(5), NF-kappaB Inhibitor : CK(2446) : AC(1436), Tumor Necrosis Factor (TNF) Alpha Inhibitor : CK(4357) : AC(1763)
Additional Keywords : Anti-Inflammatory Agents, Colitis, Interleukin-12 downregulation, Tangeretin

Tangeretin inhibits the proliferation of human breast cancer cells.

Article Published Date : Apr 03, 2018
Study Type : In Vitro Study
Additional Links
Substances : Tangeretin : CK(38) : AC(24)
Diseases : Breast Cancer : CK(5066) : AC(1738), Breast Cancer: Triple Negative : CK(551) : AC(337)
Pharmacological Actions : Antiproliferative : CK(4773) : AC(3450)
Additional Keywords : Antiproliferative : CK(65) : AC(52), Breast Cancer : CK(2) : AC(1), Breast Cancer: Triple Negative, Tangeretin

Tangeretin may be a therapeutic agent for glioblastoma treatment.

Article Published Date : Jun 30, 2016
Study Type : In Vitro Study
Additional Links
Substances : Tangeretin : CK(38) : AC(24)
Diseases : Glioblastoma : CK(398) : AC(193)
Pharmacological Actions : Antiproliferative : CK(4773) : AC(3450), Apoptotic : CK(5217) : AC(3846), Cell cycle arrest : CK(1289) : AC(1006)
Additional Keywords : Antiproliferative : CK(65) : AC(52), Apoptotic, Cell cycle arrest, Glioblastoma, Tangeretin

Tangeretin not only enhanced cisplatin’s cytotoxic actions in Hep3B and HCT-116 human cancer cells but could protect against its harmful effects.

Article Published Date : Oct 24, 2016
Study Type : In Vitro Study
Additional Links
Substances : Tangeretin : CK(38) : AC(24)
Diseases : Chemotherapy-Induced Toxicity: Cisplatin : CK(612) : AC(266), Inflammation : CK(6531) : AC(1986), Lipid Peroxidation : CK(1178) : AC(476), Oxidative Stress : CK(6519) : AC(2436)
Pharmacological Actions : Anti-Inflammatory Agents : CK(12461) : AC(4729), Antioxidants : CK(14410) : AC(5758), Chemoprotective Agents : CK(356) : AC(146), Interleukin-10 upregulation : CK(105) : AC(24), NF-kappaB Inhibitor : CK(2446) : AC(1436), Tumor Necrosis Factor (TNF) Alpha Inhibitor : CK(4357) : AC(1763)
Additional Keywords : Chemotherapeutic Synergy: Cisplatin : CK(137) : AC(103), Chemotherapy-Induced Toxicity: Cisplatin, Inflammation : CK(2) : AC(2), Lipid Peroxidation, oxidative stress, Tangeretin

These results suggest that tangeretin improves insulin resistance by attenuating obesity-induced inflammation in adipose tissue.

Article Published Date : Feb 28, 2017
Study Type : In Vitro Study
Additional Links
Substances : Tangeretin : CK(38) : AC(24)
Diseases : Inflammation : CK(6531) : AC(1986), Insulin Resistance : CK(2804) : AC(602), Obesity : CK(4406) : AC(1073)
Pharmacological Actions : Anti-Inflammatory Agents : CK(12461) : AC(4729), Cyclooxygenase 2 Inhibitors : CK(1114) : AC(645), Insulin Sensitizers : CK(707) : AC(139), Interleukin-1 beta downregulation : CK(1743) : AC(868), Interleukin-6 Downregulation : CK(3054) : AC(1144), Nitric Oxide Inhibitor : CK(390) : AC(196)
Additional Keywords : Anti-Inflammatory Agents, Inflammation : CK(2) : AC(2), Insulin Resistance, obesity, Tangeretin

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2020 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.